Online Database of Chemicals from Around the World

2'-O-(2-Methoxyethyl)adenosine
[CAS# 168427-74-5]

Top Active Suppliers
Hangzhou Verychem Science And Technology Co., Ltd. China Inquire  
+86 (571) 8816-2785
+86 13606544505
lucy@verychem.com
Chemical manufacturer since 2004
chemBlink massive supplier since 2021
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Creative Peptides USA Inquire  
+1 (631) 624-4882
info@creative-peptides.com
Chemical manufacturer
chemBlink standard supplier since 2010
Amadis Chemical Co., Ltd. China Inquire  
+86 (571) 8992-5085
sales@amadischem.com
Chemical manufacturer since 2010
chemBlink standard supplier since 2015
Shanghai Perno Biotechnology Co., Ltd. China Inquire  
+86 18217200601
bush@perno.cn
QQ chat
Chemical manufacturer since 2020
chemBlink standard supplier since 2023
Allbiosyn Biotechnology Co., Ltd. China Inquire  
+86 15900695956
info@allbiosyn.com
WeChat: 15900695956
WhatsApp: 86 15900695956
Chemical manufacturer since 2023
chemBlink standard supplier since 2024
Santa Cruz Biotechnology, Inc. USA Inquire  
+1 (831) 457-3800
scbt@scbt.com
Chemical manufacturer
Toronto Research Chemicals Inc. Canada Inquire  
+1 (416) 665-9696
info@trc-canada.com
Chemical manufacturer since 1982
Complete supplier list of 2'-O-(2-Methoxyethyl)adenosine
Identification
Classification Biochemical >> Nucleoside drugs >> Nucleoside intermediate
Name 2'-O-(2-Methoxyethyl)adenosine
Synonyms (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-(2-methoxyethoxy)oxolan-3-ol
Molecular Structure CAS # 168427-74-5, 2'-O-(2-Methoxyethyl)adenosine, (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-(2-methoxyethoxy)oxolan-3-ol
Protein Sequence N
Molecular Formula C13H19N5O5
Molecular Weight 325.32
CAS Registry Number 168427-74-5
SMILES COCCO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)CO)O
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H315-H319-H335    Details
Precautionary Statements P261-P305+P351+P338    Details
SDS Available
up Discovory and Applicatios
2'-O-(2-methoxyethyl)adenosine, often abbreviated as 2'-O-(2-ME)Ado, is a modified nucleoside that represents a significant advance in stability and therapeutic potential. The compound represents an innovative step forward in nucleoside chemistry aimed at improving the efficacy of nucleoside drugs and research tools.

The synthesis of 2'-O-(2-ME)Ado stems from efforts to improve the stability and bioavailability of adenosine, a key nucleoside in cellular metabolism and signaling. By modifying the 2' position of the ribose sugar with a 2-methoxyethyl group, the researchers aimed to create a nucleoside that would resist degradation by nucleases, which often limit the effectiveness of adenosine compounds in therapeutic applications.

The chemical modification involves attaching a 2-methoxyethyl group to the 2'-hydroxyl group of adenosine, a change that prevents the compound from rapidly breaking down in biological systems. This enhancement extends the half-life of the nucleoside and increases its cellular uptake rate.

2'-O-(2-ME)Ado is being explored for use in antiviral and anticancer therapies. This modification enhances the compound's stability, making it a more effective inhibitor of nucleic acid synthesis in pathogens and cancer cells. Its increased resistance to enzymatic degradation allows it to be maintained at therapeutic levels in vivo, thus increasing its potential as a treatment for diseases involving rapid cell proliferation or viral replication.

In cell signaling studies, 2'-O-(2-ME)Ado is used to investigate the role of adenosine in regulating various physiological processes. The compound's enhanced stability makes it an ideal tool for studying adenosine receptor interactions and signaling pathways. This research helps to elucidate the mechanisms by which adenosine affects cellular function and its potential as a therapeutic target.

The unique properties of 2'-O-(2-ME)Ado provide valuable insights into drug design. The stability conferred by the 2-methoxyethyl group enables the development of novel adenosine-based drugs with improved pharmacokinetic profiles. These modifications could result in more effective drugs with fewer side effects, providing new treatment options for a range of diseases.

References

2004. Chemo-enzymatic synthesis of 2'-O-methoxyethyl ribonucleosides using a phosphodiesterase from Serratia marcescens. Applied Microbiology and Biotechnology.
DOI: https://pubmed.ncbi.nlm.nih.gov/15349700
Market Analysis Reports
List of Reports Available for 2'-O-(2-Methoxyethyl)adenosine
Related Products
2-Methoxyethoxymethyl chloride  (9E)-2'-O-[(2-Methoxyethoxy)methyl]erythromycin 9-[O-[(2-methoxyethoxy)methyl]oxime]  (alphaR)-3-(2-Methoxyethoxy)-alpha-methyl-5-oxo-1,6-naphthyridine-6(5H)-acetic acid  (2-Methoxyethoxymethyl)triethylammonium chloride  4-(2-Methoxyethoxy)-4-oxobutanoic acid  3-[3-[4-(2-Methoxyethoxy)phenyl]-1,2,4-oxadiazol-5-yl]benzoic acid  3-(2-Methoxyethoxy)propylamine  2-Methoxyethyl acetate  2-Methoxyethyl acetoacetate  2-Methoxyethyl acrylate  3-(2-Methoxyethylaminocarbonyl)benzeneboronic acid pinacol ester  4-[(2-Methoxyethyl)amino]-2-(methylthio)-5-pyrimidinecarboxylic acid  1-[(2'-Methoxyethyl)amino]-2-nitro-4-[di-(2'-hydroxyethyl)amino]benzene  N-[2-[3-[[(2-Methoxyethyl)amino]phenylmethyl]-2-oxo-1-pyrrolidinyl]ethyl]acetamide  2-(2-Methoxyethyl)benzenemethanol  1-(2-Methoxyethyl)-4-bromo-1H-pyrazole  2-Methoxyethyl cyanoacetate  2'-O-(2-Methoxyethyl)cytidine  2-Methoxyethyl ether  3'-O-(2-Methoxyethyl)guanosine